Polmacoxib

Polmacoxib is a nonsteroidal anti-inflammatory drug (NSAID) that is used in the treatment of osteoarthritis. It is a selective cyclooxygenase-2 inhibitor, which means it specifically targets and inhibits the cyclooxygenase-2 enzyme. This enzyme is responsible for the production of prostaglandins, which cause inflammation and pain in the body. By inhibiting this enzyme, polmacoxib reduces inflammation and pain.

Etymology

The name "polmacoxib" is derived from the drug's chemical structure. The "pol" refers to its polymeric nature, "ma" refers to its macrocyclic structure, and "coxib" is a common suffix used for cyclooxygenase-2 inhibitors.

Pharmacology

Polmacoxib works by selectively inhibiting the cyclooxygenase-2 enzyme. This enzyme is responsible for the production of prostaglandins, which are chemicals that promote inflammation, pain, and fever. By inhibiting this enzyme, polmacoxib reduces these symptoms.

Clinical Use

Polmacoxib is used in the treatment of osteoarthritis. It is typically prescribed for patients who have not responded to other treatments, or who cannot take other NSAIDs due to side effects.

Side Effects

Like all NSAIDs, polmacoxib can cause side effects. These can include stomach upset, nausea, dizziness, and headache. In rare cases, it can cause serious side effects such as heart attack or stroke.

Related Terms

• Nonsteroidal anti-inflammatory drug
• Cyclooxygenase-2
• Prostaglandin
• Osteoarthritis

Polmacoxib Resources
Latest articles Most recent articles Ongoing trials	Wikipedia